Safety and efficacy of balloon pulmonary valvuloplasty
- 15 March 2012
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 80 (4), 663-672
- https://doi.org/10.1002/ccd.23473
Abstract
Balloon pulmonary valvuloplasty (BPV) is the treatment of choice for patients with pulmonary valve stenosis (PS); however, safety and efficacy outcomes are lacking in the current era. Demographic, procedural, and adverse event (AE) data were prospectively collected using a multicenter registry (C3PO) and cases performed between 02/07 and 06/10 at eight institutions. The registry was queried for cases of isolated BPV. Multivariable models were built to determine risk factors for procedure failure and adverse outcomes. 211 cases were included (45%, P = 0.03). Risk factors for procedural failure included moderate or severe pulmonary valve thickening (OR 2.9, CI 1–8.3), and presence of supravalve PS (OR 9.6, CI 2.7–33.8). Low severity AEs (levels 1–2) occurred in 9% of patients and higher severity AEs (levels 3–5) occurred in 3% of patient; there were no deaths. Risk factors for any AE (levels 1–5) were age below 1 month (OR 3.5, CI 1.3–8.9), as well as operator experience of less than 10 years (OR 3.8, CI 1.5–9.9). Procedural success is common and AEs, especially higher severity AEs, are rare for BPV in patients with isolated PS. Results have improved considerably when compared to historical data. © 2012 Wiley Periodicals Inc.Keywords
This publication has 18 references indexed in Scilit:
- Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM)JACC: Cardiovascular Interventions, 2011
- Procedure-Type Risk Categories for Pediatric and Congenital Cardiac CatheterizationCirculation: Cardiovascular Interventions, 2011
- Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 – Nomenclature of complications associated with interventional cardiology)Cardiology in the Young, 2011
- Adverse event rates in congenital cardiac catheterization — A multi‐center experienceCatheterization and Cardiovascular Interventions, 2009
- Treatment of critical pulmonary valve stenosis by balloon dilatation in the neonateAmerican Heart Journal, 1996
- Morphologic and hemodynamic consequences after percutaneous balloon valvotomy for neonatal pulmonary stenosis: Medium-term follow-upJournal of the American College of Cardiology, 1996
- Balloon dilation of critical valvar pulmonary stenosis in the first month of lifeCatheterization and Cardiovascular Diagnosis, 1995
- Right ventricular outflow reconstruction with cryopreserved homografts in pediatric patients: Intermediate-term follow-up with serial echocardiographic assessmentJournal of the American College of Cardiology, 1994
- Balloon pulmonary valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies RegistryThe American Journal of Cardiology, 1990
- Morphologic changes induced by dilation of the pulmonary valve anulus with overlarge balloons in normal newborn lambsThe American Journal of Cardiology, 1985